Development of Advanced Therapy Medicinal Products in Europe

White papers - 1 March 2018

Development of Advanced Therapy Medicinal Products in Europe

 

Advanced Therapy Medicinal Products are innovative and complex medicinal products for which successful development requires a good understanding of the applicable regulatory requirements.

 

This WhitePaper on Advanced Therapy Medicinal Products (ATMP) in Europe, adapted from the article published in the Gazette de l’AFAR N°94 in January 2017, provides:

  • A review of the regulatory background applicable to ATMP with a focus on the main measures laid down by the Regulation specifically applicable to ATMPs i.e. Regulation EC N° 1394/2007;
  • Points to consider for the development of these types of therapies;
  • An analysis of effectiveness and limitations of the measures laid down by the Regulation on ATMPs to foster the development of these medicinal products.

Did you like this article? Share on social networks:

Download the
White Paper


Thank you for your reply

You can download the file below

Download

Discover our last white Paper

Learn more